Selected article for: "different time and post infection"
Author: Longlong Si; Haiqing Bai; Melissa Rodas; Wuji Cao; Crystal Yur Oh; Amanda Jiang; Atiq Nurani; Danni Y Zhu; Girija Goyal; Sarah Gilpin; Rachelle Prantil-Baun; Donald E. Ingber
Title: Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics
  • Document date: 2020_4_14
    • ID: mrgw2mnx_17
    Snippet: When we added nafamostat or oseltamivir at different time points during influenza infection on-chip, both nafamostat and oseltamivir exhibited prophylactic and therapeutic effects (Fig. 3F) . However, the therapeutic effects of oseltamivir were detected only when it was administered within 48 h post-infection (Fig. 3F) . This is consistent with the observation that oseltamivir is only recommended for clinical use within 2 days of influenza infect.....
    Document: When we added nafamostat or oseltamivir at different time points during influenza infection on-chip, both nafamostat and oseltamivir exhibited prophylactic and therapeutic effects (Fig. 3F) . However, the therapeutic effects of oseltamivir were detected only when it was administered within 48 h post-infection (Fig. 3F) . This is consistent with the observation that oseltamivir is only recommended for clinical use within 2 days of influenza infection 19 , which is one of the important limitations of this author/funder. All rights reserved. No reuse allowed without permission.

    Search related documents:
    Co phrase search for related documents
    • different time and important limitation: 1
    • different time and influenza infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • different time and post infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • different time and therapeutic effect: 1, 2, 3, 4
    • different time point and influenza infection: 1
    • different time point and post infection: 1
    • important limitation and influenza infection: 1
    • influenza infection and post infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • influenza infection and therapeutic effect: 1, 2, 3, 4, 5, 6
    • post infection and therapeutic effect: 1, 2, 3, 4, 5
    • post infection and therapeutic prophylactic effect: 1